Naohiro Kamiya

Statistics

Publications

Citations

301

H-Index

Active since

1997

Affiliations

Mitsubishi Tanabe Pharma Corporation(Current)

Hiroshima University

Mitsubishi Chemical (Japan)

Toranomon Hospital

Mitsubishi Group (Japan)

Naohiro Kamiya is an author at Mitsubishi Tanabe Pharma Corporation specializing in viral hepatitis, antiviral therapy, and viral hepatitis treatment.

Publications per year

1997–2012

Publications

Rapid emergence of telaprevir resistant hepatitis C virus strain from wildtype clone in vivo

Nobuhiko Hiraga, Michio Imamura, Hiromi Abe et al. · Hepatology · 2011 · 74 citations

Life Sciences, Infectious Diseases, Molecular Biology +17

Elimination of hepatitis C virus by short term NS3-4A and NS5B inhibitor combination therapy in human hepatocyte chimeric mice

Eiji Ohara, Nobuhiko Hiraga, Michio Imamura et al. · Journal of Hepatology · 2010 · 49 citations

Pharmacy, Pharmacology, Pharmacotherapy +9

Practical evaluation of a mouse with chimeric human liver model for hepatitis C virus infection using an NS3-4A protease inhibitor

Naohiro Kamiya, E Iwao, Nobuhiko Hiraga et al. · Journal of General Virology · 2010 · 34 citations

Pharmacy, Infectious Diseases, Pharmacokinetics +17

2-Amino-6-arylthio-9-[2-(phosphonomethoxy)ethyl]purine Bis(2,2,2-trifluoroethyl) Esters as Novel HBV-Specific Antiviral Reagents

Kouichi Sekiya, Hideaki Takashima, Naoko Ueda et al. · Journal of Medicinal Chemistry · 2002 · 33 citations

Medicine, Medicinal Chemistry, Pharmacology +13

Safety, pharmacokinetics and resistant variants of telaprevir alone for 12 weeks in hepatitis C virus genotype 1b infection

I. Yamada, Fumitaka Suzuki, Naohiro Kamiya et al. · Journal of Viral Hepatitis · 2011 · 30 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

1–5 of 9